A case of histopathologically typical toxic epidermal necrolysis despite no visible blisters or erosive lesions

Journal of Dermatology

Volumn 32, Issue 8, 2005, Pages 654-660

  Kakeda, Masato ^a,b   Tohyama, Mikiko ^c   Iwasaki, Junji ^a   Hashimoto, Koji ^c   Mizutani, Hitoshi ^b  

^a Kinan Hospital   (Japan)

^b MIE UNIVERSITY   (Japan)

^c EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

DIHS; Drug eruption; EEM; Hypersensitivity; SJS

Indexed keywords

ALLOPURINOL; PREDNISOLONE;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG HYPERSENSITIVITY; ERYTHRODERMA; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; LIVER CIRRHOSIS; LIVER FAILURE; MALE; POLYMERASE CHAIN REACTION; RASH; SERODIAGNOSIS; TOXIC EPIDERMAL NECROLYSIS;

EID: 25144439071     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2005.tb00817.x     Document Type: Article

References (17)

1. Lyell A: Toxic epidermal necrolysis: An eruption resembling scalding of the skin, Br J Dermatol, 68: 355-361, 1956.
2. Roujeau JC: The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification, J Invest Dermatol, 102: 28S-30S, 1994.
3. Hashimoto K: A study for diagnostic criteria and medical guideline for Stevens-Johnson syndrome, toxic epidermal necrolysis, hypersensitivity syndrome, in Hashimoto K (ed): Ministry of Health, Labour and Welfare Report: A Study for Diagnostic Criteria and Medical Guidelines for Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, Hypersensitivity Syndrome, Ministry of Health, Labour and Welfare, Tokyo, 2002, pp 1-4.
4. Iijima M: Diagnostic criteria for toxic epidermal necrolysis, in Hashimoto K (ed): Ministry of Health, Labour and Welfare Report: A Study for Diagnostic Criteria and Medical Guidelines for Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, Hypersensitivity Syndrome, Ministry of Health, Labour and Welfare, Tokyo, 2002, p 6.
5. Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P: SCORTEN: a severity-of-illness score for toxic epidermal necrolysis, J Invest Dermatol, 115: 149-153, 2000.
6. Roujeau JC, Stern RS: Severe adverse cutaneous reactions to drugs, N Engl J Med, 331: 1272-1285, 1994.
7. Tohyama M, Hashimoto K: Drug hypersensitivity syndrome and human herpesvirus 6 reactivation, Arch Dermatol, 138: 268-269, 2002.
8. Hashimoto K, Yasukawa M, Tohyama M: Human herpesvirus 6 and drug allergy, Curr Opin Allergy Clin Immunol, 3: 255-260, 2003.
9. Hashimoto K: Diagnostic criteria for drug-induced hypersensitivity syndrome, in Hashimoto K (ed): Ministry of Health, Labour and Welfare Report: A Study for Diagnostic Criteria and Medical Guidelines for Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, Hypersensitivity Syndrome, Ministry of Health, Labour and Welfare, Tokyo, 2002. pp 7-8.
10. Chodorowska G, Czelej D, Niewiedziol M: Activity of Tumor Necrosis Factor-alpha (TNF-alpha) and its soluble type I receptor (p55TNF-R) in some drug-induced cutaneous reactions, Ann Univ Mariae Curie Sklodowska [Med], 58: 50-56, 2003.
11. Sugimoto Y, Mizutani H, Sato T, Kawamura N, Ohkouchi K, Shimizu M: Toxic epidermal necrolysis with severe gastrointestinal mucosal cell death: A patient who excreted long tubes of dead intestinal epithelium, J Dermatol, 25: 533-538, 1998.
12. Bachot N, Revuz J, Roujeau JC: Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: A prospective noncomparative study showing no benefit on mortality or progression, Arch Dermatol, 139: 33-36, 2003.
13. Inachi S, Mizutani H, Shimizu M: Epidermal apoptotic cell death in erythema multiforme and Stevens-Johnson syndrome: Contribution of perforin-positive cell infiltration, Arch Dermatol, 133: 845-849, 1997.
14. Stern RS, Chan HL: Usefulness of case report literature in determining drugs responsible for toxic epidermal necrolysis, J Am Acad Dermatol, 21: 317-322, 1989.
15. Roujeau JC, Kelly JP, Naldi L, et al: Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis, N Engl J Med, 333: 1600-1607, 1995.
16. Rzany B, Correia O, Kelly JP, Naldi L, Auquier A, Stern R: Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions, Lancet, 353: 2190-2194, 1999.
17. Iijima M: Severe drug eruptions; Stevens-Johnson syndrome, in Tamaki K (ed): Comprehensive Handbook of Clinical Dermatology, vol.5, Drug Eruption and Toxicoderma, Nakayama-shoten, Tokyo, 2004, pp 36-45. (In Japanese)